Co-expression of VEGF and CA9 in ovarian high-grade serous carcinoma and relationship to survival (Q84380481)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699808%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Co-expression of VEGF and CA9 in ovarian high-grade serous carcinoma and relationship to survival (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699808%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699808%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Emma Williams

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699808%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Robert Moss

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699808%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Lindy Durrant

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699808%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Suha Deen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699808%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

15 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699808%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699808%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

461

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699808%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699808%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

33-39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699808%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00428-012-1252-9

5 February 2020

exact match

0 references

cites work

Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas

1 reference

12 December 2020

Validation of tissue microarray technology in ovarian carcinoma

1 reference

12 December 2020

Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours

1 reference

12 December 2020

Hypoxia-inducible expression of tumor-associated carbonic anhydrases

1 reference

12 December 2020

Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer

1 reference

12 December 2020

Responses to salvage chemotherapy in ovarian cancer: a critical need for precise definitions of the treated population

1 reference

12 December 2020

Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma

1 reference

12 December 2020

Analysis of DNA sequences in forty-year-old paraffin-embedded thin-tissue sections: a bridge between molecular biology and classical histology

1 reference

12 December 2020

Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation

1 reference

12 December 2020

Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies

1 reference

12 December 2020

Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.

1 reference

12 December 2020

Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy

1 reference

12 December 2020

X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization

1 reference

12 December 2020

Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro

1 reference

12 December 2020

Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer

1 reference

12 December 2020

Validation of tissue microarray technology in breast carcinoma

1 reference

12 December 2020

Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix

1 reference

12 December 2020

Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia

1 reference

12 December 2020

Regulation of hypoxia-induced angiogenesis: a chaperone escorts VEGF to the dance

1 reference

12 December 2020

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

12 December 2020

Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours

1 reference

12 December 2020

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

12 December 2020

Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival

1 reference

12 December 2020

Hypoxia as a target for combined modality treatments.

1 reference

12 December 2020

Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma.

1 reference

12 December 2020

High-grade serous carcinoma of the ovary

1 reference

12 December 2020

Overview of anti-angiogenic agents in development for ovarian cancer

1 reference

12 December 2020

Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies.

1 reference

12 December 2020

Role of hypoxia in the hallmarks of human cancer

1 reference

12 December 2020

Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma

1 reference

12 December 2020

Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix

1 reference

12 December 2020

Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies?

1 reference

12 December 2020

Triple-negative breast cancer: role of antiangiogenic agents

1 reference

12 December 2020

10.1007/S00428-012-1252-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699808%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference